Manufacturer : NAT-NATCO PHARMA LIMITED
Composition : ERLOTINIB-150MG
Dose Form : TABLET
Description : ERLONAT 150MG TAB
Route Of Administration : ORAL
Pack : 1
Erlonat 150 Tablet is an anticancer medicine used for the treatment of non-small cell lung cancer. It is also used in a combination with gemcitabine to treat pancreatic cancer.
South Delhi Pharma can facilitate the supply of “Erlonat (Erlotinib)” to all locations in the world and in India after fulfilling the legal requirement (if applicable). Erlonat (Erlotinib) is a prescription drug and should be used under proper medical guidance and advice. The order will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.
Get In Touch
Get in touch with us at South Delhi Pharma (SDP), and one of our team will be on hand to help with any queries you may have.
The SDM is open
Monday to Friday.
Business hours: 09:30 A.M to 18:30 P.M.
M:+91-9891296838 / P:+91-11- 26532129
What Erlonat Capsule is?
Erlonat tablets is a specific tyrosine kinase inhibitor, indicated for the treatment of Pancreatic Cancer and Non-Small Cell Lung Cancer (NSCLC).
- Specifically, it is used to treat locally advanced as well as metastatic non-small lung cancer after the failure of at least one prior chemotherapy regimen.
- It is also used for the Non-Small Cell Lung Cancer either with EGFR exon 21 or EGFR exon 19 deletion substitution mutation which has spread to other parts of the body.
- Patients with locally advanced as well as metastatic non-small lung cancer may take this medication with the combination of gemcitabine as a first-line treatment.
What Erlotinib is?
Erlotinib in unresectable non-small cell lung cancer when added to chemotherapy improves overall survival by 19%, and improved progression-free survival (PFS) by 29%, when compared to chemotherapy alone. The U.S. Food and Drug Administration (FDA) approved erlotinib for the treatment of locally advanced or metastatic non-small cell lung cancer that has failed at least one prior chemotherapy regimen.]
In November 2005, the FDA approved erlotinib in combination with gemcitabine for treatment of locally advanced, unresectable, or metastatic pancreatic cancer.
Pharma Services and Drug Inquiries
Our Pharma Division deals only with the best, GMP certified generics and branded medication for the export market. All our products are supported by strict adherence to quality and analysis certification.
Please note for the minimum order for Exports is of US$ 300. All orders will be subject to courier charges and supplies are normally dispatched through internationally accredited courier services.
Complete the form below to receive the no-obligation price quote.
Note : We do not supply schedule-H (Example – narcotic drug or psychotropic drugs or anabolic steroids) and Anti- Abortion Drugs.